Isis Pharmaceuticals

Novel Lipid Management Therapies In High-Risk Patients - A Paradigm Shift
Seeking Alpha
Thu, 08/23/12 - 09:55 am
Aegerion
Isis Pharmaceuticals
LDL cholesterol
lomitapide
mipomersen
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
Isis Reports Financial Results And Highlights For Second Quarter 2012
Yahoo
Mon, 08/6/12 - 12:26 pm
earnings
Isis Pharmaceuticals
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Why Isis is facing a downside strategy
Yahoo/optionMONSTER
Tue, 07/3/12 - 09:51 am
Isis Pharmaceuticals
Biogen Idec Inc. and Isis Pharmaceuticals Inc. to Work Together in a Project
French Tribune, France
Sat, 06/30/12 - 04:32 pm
Biogen Idec
Isis Pharmaceuticals
muscular dystrophy
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Yahoo
Fri, 06/29/12 - 12:03 pm
Isis Pharmaceuticals
Biogen Idec
antisense
muscular dystrophy
Isis Pharmaceuticals 1st quarter loss widens, as research and development costs climb
Yahoo/AP
Tue, 05/8/12 - 10:59 am
Isis Pharmaceuticals
earnings
Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates Phase 2 Study of ISIS-APOCIIIRx
BioMedReports
Sat, 05/5/12 - 04:31 pm
TapImmune
HER-2/neu vaccine
vaccines
Isis Pharmaceuticals
ISIS-APOCIIIRx
hypertriglyceridemia
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Sat, 03/3/12 - 11:24 am
Isis Pharmaceuticals
Kynamro
Genzyme
Sanofi
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Fri, 03/2/12 - 10:37 am
earnings
Isis Pharmaceuticals
Kynamro
Keeping An Eye On Isis
Seeking Alpha
Sat, 01/14/12 - 12:08 pm
Isis Pharmaceuticals
antisense
proteomes
Biogen May Spend as Much as $299 Million on Isis Treatment for Children
Bloomberg
Wed, 01/4/12 - 09:29 am
Isis Pharmaceuticals
Biogen Idec
spinal muscular atrophy
Isis Adds Three New Drugs to Its Development Pipeline
Yahoo
Thu, 12/15/11 - 09:45 am
Isis Pharmaceuticals
ISIS-FVIIRx
ISIS-DGAT2Rx
ISIS-APOARx
nonalcoholic steatohepatitis
thrombotic diseases
atherosclerosis
3 Biotech Stocks You Should Sell Before 2012
Seeking Alpha
Thu, 12/8/11 - 11:34 am
Isis Pharmaceuticals
MannKind
Medivation
Isis Pharma posts larger 3Q loss; shares fall
Yahoo/AP
Wed, 11/9/11 - 09:11 am
earnings
Isis Pharmaceuticals
Isis Pharma files patent suit against Santaris
North Country Times, CA
Sat, 09/24/11 - 01:16 pm
Isis Pharmaceuticals
Santaris
Genzyme and Isis submit European MAA for mipomersen
Pharmabiz
Sat, 07/30/11 - 12:26 pm
Genzyme
Isis Pharmaceuticals
mipomersen
hypercholesterolemia
7 Biotechs Near 52-Week Lows
Motley Fool
Tue, 07/19/11 - 06:29 pm
Amgen
Human Genome Sciences
Isis Pharmaceuticals
Enzon
Protalix BioTherapeutics
Geron
Savient

Pages